Marsh (MRSH) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Jul, 2026Executive summary
Q2 2026 consolidated revenue rose 6% to $7.4B, with underlying growth of 5%; six-month revenue was $15.0B, up 7%.
Adjusted operating income increased 5% to $2.2B; GAAP operating income rose 4% to $1.9B.
Adjusted EPS grew 9% to $2.96 in Q2; GAAP EPS was $2.63.
Strong new business, talent acquisition, and AI investments drove growth, especially in the U.S. and international markets.
Significant legal settlement: $425M liability recorded for Greensill litigation.
Financial highlights
Q2 2026 consolidated revenue: $7.4B (+6%); six-month revenue: $15.0B (+7%).
Adjusted operating income: $2.2B (+5%); adjusted operating margin: 29.3%.
GAAP EPS: $2.63; adjusted EPS: $2.96 (+9%).
Six-month adjusted EPS: $6.25 (+8%).
Operating expenses rose 7% in Q2 and 11% YTD, driven by higher compensation and legal costs.
Outlook and guidance
Expect underlying revenue growth in 2026 similar to 2025, with continued margin expansion and solid adjusted EPS growth.
Thrive program targets $400M in annualized savings over three years, with $500M in costs.
Margin expansion anticipated to be more pronounced in Q4 than Q3.
Capital deployment guidance raised to $5.5B for 2026.
Ongoing investments in talent, technology, and innovation to support sustained performance.
Latest events from Marsh
- 8% revenue growth, record M&A, and margin expansion set up continued gains for 2025.MRSH
Q4 20249 Jul 2026 - Q1 2025 revenue up 9% to $7.1B, adjusted EPS up 5%, with strong capital returns.MRSH
Q1 20258 Jul 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202417 Jun 2026 - Revenue hit $27B, AI and acquisitions drove growth, and all voting items passed.MRSH
AGM 202621 May 2026 - Q1 2026 revenue and adjusted EPS grew 8%, but legal charges weighed on GAAP results.MRSH
Q1 202623 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.MRSH
Proxy filing31 Mar 2026 - Strong 2025 results, robust governance, and high say-on-pay support highlight this proxy filing.MRSH
Proxy filing31 Mar 2026 - 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026